narmac, your insights put everything into perspective very clearly. Thanks.

It is too bad for investors that Zenith will remain an academic institution for the forseable future. There is value here that competent value creators would know how to tap into for their shareholders.

It doesn't even seem fair to those with cancers to not turn this gem into someting that, if big money was thrown at it, might get in and save lives sooner.

Best in 2021

Toinv